Skip to main content
Erschienen in: Obesity Surgery 2/2021

22.09.2020 | Original Contributions

High Rates of Nicotine Use Relapse and Ulcer Development Following Roux-en-Y Gastric Bypass

verfasst von: Dimitrios I. Athanasiadis, Alexei Christodoulides, Sara Monfared, William Hilgendorf, Marisa Embry, Dimitrios Stefanidis

Erschienen in: Obesity Surgery | Ausgabe 2/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Given that smoking is known to contribute to gastrojejunal anastomotic (GJA) ulcers, cessation is recommended prior to laparoscopic Roux-en-Y gastric bypass (LRYGB). However, smoking relapse rates and the exact ulcer risk remain unknown. This study aimed to define smoking relapse, risk of GJA ulceration, and complications after LRYGB.

Materials and Methods

We performed a retrospective cohort study of patients who underwent primary LRYGB during 2011–2015. Initially, three patient categories were identified: lifetime non-smokers, patients who were smoking during the initial visit at the bariatric clinic or within the prior year (recent smokers), and patients who had ceased smoking more than a year prior to their initial clinic visit (former smokers). Smoking relapse, GJA ulcer occurrences, reinterventions, and reoperations were recorded and compared.

Results

A total of 766 patients were included in the analysis. After surgery, 53 (64.6%) recent smokers had resumed smoking. Out of these relapsed smokers, 51% developed GJA ulcers compared with 14.8% in non-relapsed recent smokers, 16.1% in former smokers, and 6% in lifetime nonsmokers (p < 0.001). Furthermore, relapsed smokers required more frequently endoscopic reinterventions (60.4%) compared with non-relapsed smokers (20.8%, p < 0.001), former smokers (20.7%, p < 0.001), and lifetime non-smokers (15.4%, p < 0.001). Additionally, relapsed smokers required a reoperation (18.9%) more often than non-relapsed recent smokers (5.7%, p < 0.001) and lifetime non-smokers (1.3%, p < 0.001).

Conclusion

Smokers relapse frequently after LRYGB, and the majority experience GJA complications. They should be counseled about this risk preoperatively and directed towards less ulcerogenic procedures when possible. Alternatively, longer periods of preoperative smoking abstinence might be needed.
Literatur
1.
Zurück zum Zitat Maciejewski ML, Arterburn DE, Van Scoyoc L, et al. Bariatric surgery and long-term durability of weight loss. JAMA Surg. 2016;151(11):1046–55.CrossRef Maciejewski ML, Arterburn DE, Van Scoyoc L, et al. Bariatric surgery and long-term durability of weight loss. JAMA Surg. 2016;151(11):1046–55.CrossRef
2.
Zurück zum Zitat Nasser H, Ivanics T, Leonard-Murali S, et al. Perioperative outcomes of laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy in super-obese and super-super-obese patients: a national database analysis. Surg Obes Relat Dis. 2019; Nasser H, Ivanics T, Leonard-Murali S, et al. Perioperative outcomes of laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy in super-obese and super-super-obese patients: a national database analysis. Surg Obes Relat Dis. 2019;
3.
Zurück zum Zitat Schneider BE, Villegas L, Blackburn GL, et al. Laparoscopic gastric bypass surgery: outcomes. J Laparoendosc Adv Surg Tech A. 2003;13(4):247–55.CrossRef Schneider BE, Villegas L, Blackburn GL, et al. Laparoscopic gastric bypass surgery: outcomes. J Laparoendosc Adv Surg Tech A. 2003;13(4):247–55.CrossRef
4.
Zurück zum Zitat Coblijn UK, Goucham AB, Lagarde SM, et al. Development of ulcer disease after Roux-en-Y gastric bypass, incidence, risk factors, and patient presentation: a systematic review. Obes Surg. 2014;24(2):299–309.CrossRef Coblijn UK, Goucham AB, Lagarde SM, et al. Development of ulcer disease after Roux-en-Y gastric bypass, incidence, risk factors, and patient presentation: a systematic review. Obes Surg. 2014;24(2):299–309.CrossRef
5.
Zurück zum Zitat Coblijn UK, Lagarde SM, de Castro SM, et al. Symptomatic marginal ulcer disease after Roux-en-Y gastric bypass: incidence, risk factors and management. Obes Surg. 2015;25(5):805–11.CrossRef Coblijn UK, Lagarde SM, de Castro SM, et al. Symptomatic marginal ulcer disease after Roux-en-Y gastric bypass: incidence, risk factors and management. Obes Surg. 2015;25(5):805–11.CrossRef
6.
Zurück zum Zitat Spaniolas K, Yang J, Crowley S, et al. Association of long-term anastomotic ulceration after Roux-en-Y gastric bypass with tobacco smoking. JAMA Surg. 2018;153(9):862–4.CrossRef Spaniolas K, Yang J, Crowley S, et al. Association of long-term anastomotic ulceration after Roux-en-Y gastric bypass with tobacco smoking. JAMA Surg. 2018;153(9):862–4.CrossRef
7.
Zurück zum Zitat Mechanick JI, Youdim A, Jones DB, et al. Clinical Practice Guidelines for the Perioperative Nutritional, Metabolic, and Nonsurgical Support of the Bariatric Surgery Patient—2013 Update: Cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery. Obesity. 2014;21(0 1): S1–27. Mechanick JI, Youdim A, Jones DB, et al. Clinical Practice Guidelines for the Perioperative Nutritional, Metabolic, and Nonsurgical Support of the Bariatric Surgery Patient—2013 Update: Cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery. Obesity. 2014;21(0 1): S1–27.
8.
Zurück zum Zitat Simmons VN, Litvin EB, Jacobsen PB, et al. Predictors of smoking relapse in patients with thoracic cancer or head and neck cancer. Cancer. 2013;119(7):1420–7.CrossRef Simmons VN, Litvin EB, Jacobsen PB, et al. Predictors of smoking relapse in patients with thoracic cancer or head and neck cancer. Cancer. 2013;119(7):1420–7.CrossRef
9.
Zurück zum Zitat Wittgrove AC, Clark GW, Tremblay LJ. Laparoscopic gastric bypass, Roux-en-Y: preliminary report of five cases. Obes Surg. 1994;4(4):353–7.CrossRef Wittgrove AC, Clark GW, Tremblay LJ. Laparoscopic gastric bypass, Roux-en-Y: preliminary report of five cases. Obes Surg. 1994;4(4):353–7.CrossRef
10.
Zurück zum Zitat Gajdos C, Hawn MT, Campagna EJ, et al. Adverse effects of smoking on postoperative outcomes in cancer patients. Ann Surg Oncol. 2012;19(5):1430–8.CrossRef Gajdos C, Hawn MT, Campagna EJ, et al. Adverse effects of smoking on postoperative outcomes in cancer patients. Ann Surg Oncol. 2012;19(5):1430–8.CrossRef
11.
Zurück zum Zitat Musallam KM, Rosendaal FR, Zaatari G, et al. Smoking and the risk of mortality and vascular and respiratory events in patients undergoing major surgery. JAMA Surg. 2013;148(8):755–62.CrossRef Musallam KM, Rosendaal FR, Zaatari G, et al. Smoking and the risk of mortality and vascular and respiratory events in patients undergoing major surgery. JAMA Surg. 2013;148(8):755–62.CrossRef
12.
Zurück zum Zitat Schmid M, Sood A, Campbell L, et al. Impact of smoking on perioperative outcomes after major surgery. Am J Surg. 2015;210(2):221–9 e6.CrossRef Schmid M, Sood A, Campbell L, et al. Impact of smoking on perioperative outcomes after major surgery. Am J Surg. 2015;210(2):221–9 e6.CrossRef
13.
Zurück zum Zitat Haskins IN, Amdur R, Vaziri K. The effect of smoking on bariatric surgical outcomes. Surg Endosc. 2014;28(11):3074–80.CrossRef Haskins IN, Amdur R, Vaziri K. The effect of smoking on bariatric surgical outcomes. Surg Endosc. 2014;28(11):3074–80.CrossRef
14.
Zurück zum Zitat Khullar D, Maa J. The impact of smoking on surgical outcomes. J Am Coll Surg. 2012;215(3):418–26.CrossRef Khullar D, Maa J. The impact of smoking on surgical outcomes. J Am Coll Surg. 2012;215(3):418–26.CrossRef
15.
Zurück zum Zitat Haskins IN, Nowacki AS, Khorgami Z, et al. Should recent smoking be a contraindication for sleeve gastrectomy? Surg Obes Relat Dis. 2017;13(7):1130–5.CrossRef Haskins IN, Nowacki AS, Khorgami Z, et al. Should recent smoking be a contraindication for sleeve gastrectomy? Surg Obes Relat Dis. 2017;13(7):1130–5.CrossRef
16.
Zurück zum Zitat Gribben JL, Ilonzo N, Neifert S, Michael Leitman I. Predictors of reoperation and failure to rescue in bariatric surgery. JSLS. 2018;22(1):e2017.00074. Gribben JL, Ilonzo N, Neifert S, Michael Leitman I. Predictors of reoperation and failure to rescue in bariatric surgery. JSLS. 2018;22(1):e2017.00074.
17.
Zurück zum Zitat Carlson BB, Burton DC, Jackson RS, et al. Recidivism rates after smoking cessation before spinal fusion. Orthopedics. 2016;39(2):e318–22.CrossRef Carlson BB, Burton DC, Jackson RS, et al. Recidivism rates after smoking cessation before spinal fusion. Orthopedics. 2016;39(2):e318–22.CrossRef
18.
Zurück zum Zitat Fringeli Y, Worreth M, Langer I. Gastrojejunal anastomosis complications and their management after laparoscopic Roux-en-Y gastric bypass. J Obes. 2015;2015:698425.CrossRef Fringeli Y, Worreth M, Langer I. Gastrojejunal anastomosis complications and their management after laparoscopic Roux-en-Y gastric bypass. J Obes. 2015;2015:698425.CrossRef
19.
Zurück zum Zitat Sapala JA, Wood MH, Sapala MA, et al. Marginal ulcer after gastric bypass: a prospective 3-year study of 173 patients. Obes Surg. 1998;8(5):505–16.CrossRef Sapala JA, Wood MH, Sapala MA, et al. Marginal ulcer after gastric bypass: a prospective 3-year study of 173 patients. Obes Surg. 1998;8(5):505–16.CrossRef
20.
Zurück zum Zitat Dallal RM, Bailey LA. Ulcer disease after gastric bypass surgery. Surg Obes Relat Dis. 2006;2(4):455–9.CrossRef Dallal RM, Bailey LA. Ulcer disease after gastric bypass surgery. Surg Obes Relat Dis. 2006;2(4):455–9.CrossRef
21.
Zurück zum Zitat Rasmussen JJ, Fuller W, Ali MR. Marginal ulceration after laparoscopic gastric bypass: an analysis of predisposing factors in 260 patients. Surg Endosc. 2007;21(7):1090–4.CrossRef Rasmussen JJ, Fuller W, Ali MR. Marginal ulceration after laparoscopic gastric bypass: an analysis of predisposing factors in 260 patients. Surg Endosc. 2007;21(7):1090–4.CrossRef
22.
Zurück zum Zitat Wennerlund J, Gunnarsson U, Strigard K, et al. Acid-related complications after laparoscopic Roux-en-Y gastric bypass: risk factors and impact of proton pump inhibitors. Surg Obes Relat Dis. 2020;16(5):620–5.CrossRef Wennerlund J, Gunnarsson U, Strigard K, et al. Acid-related complications after laparoscopic Roux-en-Y gastric bypass: risk factors and impact of proton pump inhibitors. Surg Obes Relat Dis. 2020;16(5):620–5.CrossRef
23.
Zurück zum Zitat Bittner JI, Clingempeel NL, Wolf LG. Weight loss failure and reoperation after laparoscopic adjustable gastric banding and gastric bypass: a case-matched cohort study. Obes Surg. 2017;27(11):2885–9.CrossRef Bittner JI, Clingempeel NL, Wolf LG. Weight loss failure and reoperation after laparoscopic adjustable gastric banding and gastric bypass: a case-matched cohort study. Obes Surg. 2017;27(11):2885–9.CrossRef
24.
Zurück zum Zitat Ladak F, Dang JT, Switzer NJ, et al. Rates of reoperation and nonoperative intervention within 30 days of bariatric surgery. Surg Obes Relat Dis. 2019;15(3):431–40.CrossRef Ladak F, Dang JT, Switzer NJ, et al. Rates of reoperation and nonoperative intervention within 30 days of bariatric surgery. Surg Obes Relat Dis. 2019;15(3):431–40.CrossRef
25.
Zurück zum Zitat Tischler EH, Matsen Ko L, Chen AF, et al. Smoking increases the rate of reoperation for infection within 90 days after primary total joint arthroplasty. J Bone Joint Surg Am. 2017;99(4):295–304.CrossRef Tischler EH, Matsen Ko L, Chen AF, et al. Smoking increases the rate of reoperation for infection within 90 days after primary total joint arthroplasty. J Bone Joint Surg Am. 2017;99(4):295–304.CrossRef
26.
Zurück zum Zitat Csendes A, Burgos AM, Altuve J, et al. Incidence of marginal ulcer 1 month and 1 to 2 years after gastric bypass: a prospective consecutive endoscopic evaluation of 442 patients with morbid obesity. Obes Surg. 2009;19(2):135–8.CrossRef Csendes A, Burgos AM, Altuve J, et al. Incidence of marginal ulcer 1 month and 1 to 2 years after gastric bypass: a prospective consecutive endoscopic evaluation of 442 patients with morbid obesity. Obes Surg. 2009;19(2):135–8.CrossRef
27.
Zurück zum Zitat Palermo M, Acquafresca PA, Rogula T, et al. Late surgical complications after gastric by-pass: a literature review. Arq Bras Cir Dig. 2015;28(2):139–43.CrossRef Palermo M, Acquafresca PA, Rogula T, et al. Late surgical complications after gastric by-pass: a literature review. Arq Bras Cir Dig. 2015;28(2):139–43.CrossRef
28.
Zurück zum Zitat Tucker ON, Szomstein S, Rosenthal RJ. Surgical management of gastro-gastric fistula after divided laparoscopic Roux-en-Y gastric bypass for morbid obesity. J Gastrointest Surg. 2007;11(12):1673–9.CrossRef Tucker ON, Szomstein S, Rosenthal RJ. Surgical management of gastro-gastric fistula after divided laparoscopic Roux-en-Y gastric bypass for morbid obesity. J Gastrointest Surg. 2007;11(12):1673–9.CrossRef
29.
Zurück zum Zitat Azagury DE, Abu Dayyeh BK, Greenwalt IT, et al. Marginal ulceration after Roux-en-Y gastric bypass surgery: characteristics, risk factors, treatment, and outcomes. Endoscopy. 2011;43(11):950–4.CrossRef Azagury DE, Abu Dayyeh BK, Greenwalt IT, et al. Marginal ulceration after Roux-en-Y gastric bypass surgery: characteristics, risk factors, treatment, and outcomes. Endoscopy. 2011;43(11):950–4.CrossRef
30.
Zurück zum Zitat Marti J. Successful smoking cessation and duration of abstinence--an analysis of socioeconomic determinants. Int J Environ Res Public Health. 2010;7(7):2789–99.CrossRef Marti J. Successful smoking cessation and duration of abstinence--an analysis of socioeconomic determinants. Int J Environ Res Public Health. 2010;7(7):2789–99.CrossRef
31.
Zurück zum Zitat Gormsen J, Hjorne F, Helgstrand F. Cotinine test in evaluating smoking cessation at the day of bariatric surgery. Scand J Surg. 2019;25:1457496919866017. Gormsen J, Hjorne F, Helgstrand F. Cotinine test in evaluating smoking cessation at the day of bariatric surgery. Scand J Surg. 2019;25:1457496919866017.
32.
Zurück zum Zitat Wolvers PJD, Bruin SC, Mairuhu WM, et al. Self-reported smoking compared to serum cotinine in bariatric surgery patients: smoking is underreported before the operation. Obes Surg. 2019; Wolvers PJD, Bruin SC, Mairuhu WM, et al. Self-reported smoking compared to serum cotinine in bariatric surgery patients: smoking is underreported before the operation. Obes Surg. 2019;
33.
Zurück zum Zitat King WC, White GE, Belle SH, et al. Changes in smoking behavior before and after gastric bypass: a 7-year study. Ann Surg. 2020; online ahead of print. King WC, White GE, Belle SH, et al. Changes in smoking behavior before and after gastric bypass: a 7-year study. Ann Surg. 2020; online ahead of print.
34.
Zurück zum Zitat Walker MS, Vidrine DJ, Gritz ER, et al. Smoking relapse during the first year after treatment for early-stage non-small-cell lung cancer. Cancer Epidemiol Biomark Prev. 2006;15(12):2370–7.CrossRef Walker MS, Vidrine DJ, Gritz ER, et al. Smoking relapse during the first year after treatment for early-stage non-small-cell lung cancer. Cancer Epidemiol Biomark Prev. 2006;15(12):2370–7.CrossRef
35.
Zurück zum Zitat Sverden E, Mattsson F, Sonden A, et al. Risk factors for marginal ulcer after gastric bypass surgery for obesity: a population-based cohort study. Ann Surg. 2016;263(4):733–7.CrossRef Sverden E, Mattsson F, Sonden A, et al. Risk factors for marginal ulcer after gastric bypass surgery for obesity: a population-based cohort study. Ann Surg. 2016;263(4):733–7.CrossRef
Metadaten
Titel
High Rates of Nicotine Use Relapse and Ulcer Development Following Roux-en-Y Gastric Bypass
verfasst von
Dimitrios I. Athanasiadis
Alexei Christodoulides
Sara Monfared
William Hilgendorf
Marisa Embry
Dimitrios Stefanidis
Publikationsdatum
22.09.2020
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 2/2021
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-020-04978-3

Weitere Artikel der Ausgabe 2/2021

Obesity Surgery 2/2021 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.